Trading strategies for Thyrocare, Dr Lal Path, Metropolis amid Covid scare

Thyrocare, Dr Lal Path Labs and Metropolis are trading almost 50 per cent below their respective all-time highs, the reversal may see breakout if the key respective levels are sustained

Select states in India, including Maharashtra and Kerala, have witnessed a spike in daily Covid-19 cases. While the authorities have stepped-up their efforts to control the spike by making face masks compulsory in Maharashtra among other measures, the monsoon season coupled with re-opening of schools and offices could add to the woes for the authorities.
 

Given this background, shares of healthcare related stocks including pathologies are likely to be on investors' radar. In trades so far on Monday, shares of Thyrocare Technologies have soared 4 per cent, while Dr. Lal Path Labs and Metropolis Healthcare have witnessed over 2 per